Novo Holdings, the controlling shareholder of weight loss drugmaker Novo Nordisk A/S (NYSE:NVO), reported Wednesday income and investment returns of 60 billion Danish kroner (around $8.68 billion) for ...

While gastrointestinal issues are the most common side effects, a recent study by the University of British Columbia linked ...

A rapidly escalating trade war has socked stocks as investors weigh the fallout from President Trump’s tariff barrage.

We recently published a list of 10 Best Beaten Down Stocks to Buy According to Analysts. In this article, we are going to ...

With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help ...

(Reuters) -KKR has abandoned a private equity consortium discussing a takeover of Gerresheimer AG, Bloomberg News reported on ...

Investing.com -- KKR, a global investment firm, has withdrawn from a private equity consortium considering a takeover of Gerresheimer AG (BS: GXId ), a German company known for producing pens used to ...

Eli Lilly (LLY) leads with groundbreaking tirzepatide (Mounjaro/Zepbound), while Hims & Hers Health (HIMS) faces challenges.

Dividend stocks have been a reliable cornerstone for those who want to anchor their portfolios when markets get shaky. These ...

A Danish drugmaker has revealed a stunning increase in pollution amid plans to boost production of its popular weight loss ...

Also in this newsletter, the weight-loss drug Mounjaro makes its India debut and stock markets on ‘liberation day’ ...

In addition to the newsworthy headlines above, the PR Newswire team identified several trends shaping health industry news in ...